TITLE 33 INSURANCE

Section 54. Genetic Testing, 33-54-1 through 33-54-8.

ARTICLE 4 LIQUIDATION PROCEEDINGS

33-54-2. Definitions.

As used in this chapter, the term:

1. "Genetic testing" means laboratory tests of human DNA or chromosomes for the purpose of identifying the presence or absence of inherited alterations in genetic material or genes which are associated with a disease or illness that is asymptomatic at the time of testing and that arises solely as a result of such abnormality in genes or genetic material. For purposes of this chapter, genetic testing shall not include routine physical measurements; chemical, blood, and urine analysis; tests for abuse of drugs; and tests for the presence of the human immunodeficiency virus.
2. "Insurer" means an insurer, a fraternal benefit society, a nonprofit medical service corporation, a health care corporation, a health maintenance corporation, or a self-insured health plan not subject to the exclusive jurisdiction of the Employee Retirement Income Security Act of 1974, 29 U.S.C. Section 1001, et seq.

(Code 1981, §33-54-2, enacted by Ga. L. 1995, p. 1242, § 4.)